University of California, Davis

Total Awards: 
55
Award Value: 
$138,099,869
Major Facility Name: 
Institute for Regenerative cures
Institution type: 
Not for profit
Short Name: 
UC Davis

Awards to the Institution

Program Investigator Award Title Award Value
Early Translational II Roslyn Isseroff Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds $4,629,747
Tools and Technologies III Laura Marcu Multimodal platform combining optical and ultrasonic technologies for in vivo nondestructive evaluation of engineered vascular tissue constructs $1,834,474
Research Training II Frederick Meyers UC Davis Stem Cell Training Program $4,838,291
Conference Randi Hagerman Pathways of Neurodevelopmental Disorders (C8) $29,939
Creativity Awards Gerhard Bauer Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility $250,064
Early Translational I Alice Tarantal In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies $3,143,392
Conference Alice Tarantal 12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases $8,000
Early Translational III Walter Boyd Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair $4,631,754
SEED Grant Ebenezer Yamoah Hair Cells and Spiral Ganglion Neuron Differentiation from Human Embryonic Stem Cells $458,071
Preclinical Development Awards Diana Farmer Placental Stem Cells for the In Utero Treatment of Spina Bifida $2,182,146
Disease Team Therapy Planning I John Laird Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia $76,066
Patent Assistance Fund Awards David McGee CIRM Patent Prosecution Assistance Fund for Stem Cell Technologies - UCD $48,595
New Faculty Physician Scientist Emanual Maverakis Tunable hydrogels for therapeutic delivery of multipotent stem cells. $2,772,000
Shared Labs Alice Tarantal UC Davis Translational Human Embryonic Stem Cell Shared Research Facility $1,728,111
Conference Mark Yarborough Stem Cell Research for Neurological Disorders: A Case Study in Ethical and Policy Issues in ALS Research $1,020
Early Translational III Kyriacos Athanasiou Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells $1,735,703
SEED Grant A. Reddi hESCs for Articular Cartilage Regeneration $301,703
Preclinical Development Awards Roslyn Isseroff Scaffold for dermal regeneration containing pre-conditioned mesenchymal stem cells to heal chronic diabetic wounds $4,620,144
Disease Team Therapy Planning I Vicki Wheelock MSC engineered to produce BDNF for the treatment of Huntington's disease $97,564
Quest - Discovery Stage Research Projects Deborah Lieu Microenvironment for hiPSC-derived pacemaking cardiomyocytes $2,042,728
Disease Team Therapy Development III Peter Belafsky Tissue Engineered Recellularized Laryngotracheal Implants $3,181,162
Tools and Technologies I Alice Tarantal In Vivo Imaging for the Detection and Quantitation of Transplanted Stem/Progenitor Cells in Nonhuman Primates $799,350
Conference Alice Tarantal 11th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases $16,850
Disease Team Therapy Development - Research John Laird Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia $3,728,384
New Faculty II Paul Knoepfler Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency $2,157,255
Clinical Trial Stage Projects Mehrdad Abedi Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-selected CD34+ Cells in AIDS lymphoma patients $8,414,265
Disease Team Therapy Planning I Mehrdad Abedi Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients $66,880
Alpha Stem Cell Clinics Network Expansion Mehrdad Abedi Alpha Stem Cell Clinic for Northern and Central California $7,905,671
Basic Biology I Min Zhao Directing migration of human stem cells with electric fields $816,228
Major Facilities Larry Vanderhoef UC Davis CIRM Institute $20,082,400
Tools and Technologies I Kit Lam Discovery of adhesion ligands for pluripotent human stem cells $834,003
Conference Alice Tarantal 9th Annual Gene Therapy Symposium for Heart, Lung and Blood Diseases $12,000
Disease Team Therapy Development - Research Nancy Lane Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells $19,999,867
Comprehensive Grant Mark Zern An in vitro and in vivo comparison among three different human hepatic stem cell populations. $2,251,223
SPARK Gerhard Bauer Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility $388,645
Disease Team Therapy Planning I Nancy Lane Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis $107,750
Conference - Manage The SPARK Annual Meeting Gerhard Bauer The 2018 SPARK Annual Meeting $48,305
Basic Biology II Eric Kurzrock Differentiation of Human Embryonic Stem Cells into Urothelium $849,037
Shared Labs Alice Tarantal UC Davis Translational Human Embryonic Stem Cell Shared Research Facility $2,000,000
Transplantation Immunology William Murphy Donor natural killer (NK) cells as “veto” cells to promote donor-specific tolerance $1,257,601
Conference Alice Tarantal 10th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases $18,300
Disease Team Therapy Development - Research Vicki Wheelock MSC engineered to produce BDNF for the treatment of Huntington's disease $8,924,235
Comprehensive Grant Alice Tarantal Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells $2,166,757
Therapeutic Translational Research Projects Joseph Anderson Overexpression of HexA/HexB by lentivector expression in blood cells to treat Tay-Sachs and Sandhoff disease $883,174
Disease Team Therapy Planning I Martin Birchall Airways for Children $19,800
Inception - Discovery Stage Research Projects Alyssa Panitch Development of treatments to improve healing of ischemic wounds $235,800
Early Translational II Mark Zern Liver Cell Transplantation $4,212,621
Tools and Technologies III J. Leach Multi-modal technology for non-destructive characterization of bioengineered tissues $1,842,792
New Faculty I Chong-Xian Pan Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells $2,386,409
Conference Alice Tarantal 13th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases $10,000
Basic Biology IV Deborah Lieu Induction of Pluripotent Stem Cell-Derived Pacemaking Cells $1,333,689
Early Translational I Jan Nolta Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders $2,615,674
Quest - Discovery Stage Research Projects David Segal MSC delivery of an artificial transcription factor to the brain as a treatment for Angelman Syndrome $1,087,572
Training Grant I-1 Frederick Meyers Stem Cell Research Training Grant $1,780,859
Inception - Discovery Stage Research Projects Alice Tarantal Enhanced Branching Morphogenesis and Pluripotent Cell Lineage Differentiation for Pediatric Regenerative Therapies $235,800
Total:
$138,099,870.00
Icon for xls export